Navigation Links
Weill Cornell Research Reveals Secrets Of Trafficking Within Cells

As you read this, cells in your eye are transmitting information to your brain, while cells in your heart and arteries work just as hard to keep that brain alive. Every one of these cells -- and others throughout the body -- depends on an internal process called endocytosis to keep the flow of cellular nutrients and information healthy and strong.

It's an incredibly important life process, and now researchers at Weill Medical College of Cornell University in New York City have used an exciting new technology to better understand how one key player -- a protein called clathrin -- helps regulate endocytosis like a well-oiled machine. It may also give us insights into the kinds of disease states that can happen when clathrin-regulated endocytosis goes wrong.

The findings, already published online, will appear in the April print edition of Molecular Biology of the Cell, whose editors have chosen to highlight the Weill Cornell research due to its quality and broader significance to the field.

"This is a kind of cellular fine-tuning, and we know that deficits in this fine-tuning can wreak havoc on health," said Dr. Timothy Ryan, Professor of Biochemistry at Weill Cornell Medical College. "It's well known in obesity, for example, that even a tiny change in metabolic rate results in someone becoming obese."

Endocytosis involves the shuttling back and forth of vesicles (sac-like objects) filled with nutrients, neurotransmitters, or other compounds; usually from the cell surface to the cell interior.

Previous work at Dr. Ryan's lab has helped clarify the role of some of the key players in this process, including a ubiquitous protein called clathrin, found in nearly every cell type.

"From our previous work in brain synapses, we've learned that endocytosis is a machine that really runs quite fast, and in this latest study we were trying to figure out what those speed limits are, especially with regard to varying amounts of clathrin
'"/>

Source:Cornell University


Page: 1 2 3

Related biology news :

1. Cornell finds natural selection in humans
2. Cornell researchers find serious fish virus in Northeast for first time
3. Cornell researcher helping develop quick, cheap HIV/AIDS test
4. Cornell lab confirms deadly fish virus spreading to new species
5. Researchers discover way to make cells in the eye sensitive to light
6. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
7. Researchers find how protein allows insects to detect and respond to pheromones
8. Researchers Uncover Key Step In Manufacture of Memory Protein
9. Research advances quest for HIV-1 vaccine
10. Research on Worms Yields Clues on Aging
11. Researchers reveal the infectious impact of salmon farms on wild salmon
Post Your Comments:
(Date:1/22/2015)... EyeLock, Inc. , a market leader of iris-based identity authentication ... to the new role of Senior Vice President of Mobile ... mobile platforms and wearable solutions for EyeLock,s technologies. Gerber brings ... semiconductor industry to his role at EyeLock, with expertise in ...
(Date:12/24/2014)...  Since its launch in December 2014, the 1U™ ... of trying to remember their usernames and passwords through replacing ... smartphones. To assist people who have struggled to remember usernames ... 1U and focuses on redefining identity, announced today that it ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
... of prostate cancer in mice and has beneficial effects on ... metabolism, UC Davis and the U.S. Department of Agriculture Western ... study, by Paul Davis, nutritionist in the Department of Nutrition ... the findings today at the annual national meeting of the ...
... Department of Energy (DOE) Joint Genome Institute (JGI) has ... 13th Annual Applied Ergonomics Conference held March 22-25, 2010 ... Improvement Initiatives category, the DOE JGI,s entry is "Empowering ... the DOE JGI program that help promote awareness of ...
... ESA,s TIGER II initiative has selected 20 project proposals ... learn more about the water cycle and to improve ... results and achievements of its precursor TIGER I, which ... to bridge Africa,s water information gap using Earth-observation (EO) ...
Cached Biology News:Walnuts slow prostate tumors in mice 2DOE JGI vying for 2010 Ergo Cup 2ESA's TIGER II to support 20 water projects in Africa 2ESA's TIGER II to support 20 water projects in Africa 3
(Date:1/22/2015)... 22. 2015  Varian Medical Systems (NYSE: VAR ), ... for its commitment to sustainability with inclusion on a prestigious ... highest ranked healthcare equipment company among the Corporate Knights Global ... Economic Forum at Davos, Switzerland . ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 On Friday, ... 83, the Omnibus and Continuing Resolution Appropriations Act of ... condition eligible to receive funding through the Congressionally Directed ... Defense (DoD). The Hydrocephalus Association (HA), working in conjunction ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... Minimal Effect on Heart Rhythm ... Changes in Schizophrenia Patients, VIENNA, Austria, Oct. 17 ... Organon -- is effective,in treating acute manic episodes associated with bipolar ... this week at,the 20th European College of Neuropsychopharmacology (ECNP) Congress. ...
... PRINCETON, N.J., Oct. 16 Bristol-Myers Squibb,Company (NYSE: ... Food and Drug,Administration (FDA) has granted approval of ... with metastatic or locally,advanced breast cancer in patients ... and capecitabine. The FDA has also granted,approval of ...
... Management Team, ROCKVILLE, Md., Oct. 16 ... company developing,therapeutics for the treatment of cancer and ... has been appointed its Senior Vice,President, Research and ... officer of EntreMed by the Board of Directors, ...
Cached Biology Technology:Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 2Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 3Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 4Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 5Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 6FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 2FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 3FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 4FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 5FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 6FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 7EntreMed Appoints Senior Vice President of Research and Development 2EntreMed Appoints Senior Vice President of Research and Development 3EntreMed Appoints Senior Vice President of Research and Development 4
... sensitive laser confocal systems designed for rapid ... that meet your expectations, differentiating between a ... the signal on the bottom as well ... for increased sensitivity. Results with VersArray ChipReader ...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not...
... System is an automated multiplexing platform that ... detection, pathogen sequence detection and pharmacogenetics applications. ... applied to an open and flexible electronic ... reused until all tests sites have been ...
... : GeneTraffic is built to be a ... GeneTraffic provides visual and computational tools to ... to analysis. , Data and Project ... the MIAME (Minimum Information About a Microarray ...
Biology Products: